Outline of New ESMO Guidelines Indicates Inclusion of FOTIVDA® (Tivozanib) for Patients with Advanced Renal Cell Carcinoma

8 Cancer Research UK. Kidney cancer rates are increasing, so what’s fuelling the surge? Available at: http://scienceblog.cancerresearchuk.org/2017/04/24/kidney-cancer-rates-are-increasing-so-whats-fue...

Outline of New ESMO Guidelines Indicates Inclusion of FOTIVDA® (Tivozanib) for Patients with Advanced Renal Cell Carcinoma

8 Cancer Research UK. Kidney cancer rates are increasing, so what’s fuelling the surge? Available at: http://scienceblog.cancerresearchuk.org/2017/04/24/kidney-cancer-rates-are-increasing-so-whats-fue...